Accuracy and timeliness of preoperative evaluation can be improved for suspected lung cancer patients

This article originally appeared here.
Accuracy, Timing of Pre-Op Lung CA Evaluation Can Be Improved
Accuracy, Timing of Pre-Op Lung CA Evaluation Can Be Improved

(HealthDay News) -- For suspected lung cancer patients, the thoroughness, accuracy, and timeliness of preoperative evaluation could be improved, according to research published online July 30 in the Annals of Thoracic Surgery.

Nicholas Faris, M.Div., from the University of Memphis in Tennessee, and colleagues conducted a retrospective review of clinical records to examine the presurgical evaluation of suspected lung cancer patients. Data were included for 614 recipients of lung resection at two institutions. Patients were classified into five "nodal points": lesion detection, diagnostic biopsy, radiologic staging, invasive staging, and treatment.

The researchers found that 92 percent of patients had lung cancer, 5 percent had a non-lung primary tumor, and 3 percent had a benign lesion. Most patients (98 percent) had preoperative computed tomography (CT) scans, while 27, 22, and 88 percent, respectively, had no preoperative diagnostic procedure, no preoperative positron emission tomography (PET)/CT scans, and no invasive preoperative staging. Only 10 percent had CT, PET/CT, and invasive staging. Of patients with an invasive staging test, 21 percent had mediastinal nodal metastasis at resection. The median duration was 84 days from initial lesion identification to resection, 28 days from lesion identification to diagnostic biopsy, and 40 days from diagnostic biopsy to surgery.

"There is opportunity for improvement in the thoroughness, accuracy, and timeliness of preoperative evaluation of suspected lung cancer patients in this community cohort," the authors write.

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs